OHI
Income statement / Annual
Last year (2025), Omega Healthcare Investors, Inc.'s total revenue was $1.20 B,
an increase of 13.95% from the previous year.
In 2025, Omega Healthcare Investors, Inc.'s net income was $590.11 M.
See Omega Healthcare Investors, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$1.20 B |
$1.05 B |
$949.74 M |
$878.24 M |
$1.06 B |
$892.38 M |
$928.83 M |
$881.68 M |
$908.39 M |
$900.83 M |
| Cost of Revenue |
$664.93 M
|
$14.56 M
|
$15.03 M
|
$15.50 M
|
$12.26 M
|
$12.32 M
|
$14.93 M
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$533.17 M
|
$1.04 B
|
$934.72 M
|
$862.74 M
|
$1.05 B
|
$880.07 M
|
$913.90 M
|
$881.68 M
|
$908.39 M
|
$900.83 M
|
| Gross Profit Ratio |
0.45
|
0.99
|
0.98
|
0.98
|
0.99
|
0.99
|
0.98
|
1
|
1
|
1
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$88.00 M
|
$81.50 M
|
$69.40 M
|
$64.63 M
|
$59.89 M
|
$57.87 M
|
$63.51 M
|
$47.68 M
|
$45.87 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$0.00
|
$88.00 M
|
$81.50 M
|
$69.40 M
|
$64.63 M
|
$59.89 M
|
$57.87 M
|
$63.51 M
|
$47.68 M
|
$45.87 M
|
| Other Expenses |
-$216.27 M
|
$289.17 M
|
$364.24 M
|
$401.07 M
|
$419.75 M
|
$367.92 M
|
$304.28 M
|
$320.58 M
|
$545.53 M
|
$295.01 M
|
| Operating Expenses |
-$216.27 M
|
$377.17 M
|
$445.74 M
|
$470.47 M
|
$484.38 M
|
$427.81 M
|
$362.15 M
|
$384.09 M
|
$593.21 M
|
$340.87 M
|
| Cost And Expenses |
$448.66 M
|
$391.73 M
|
$460.77 M
|
$485.97 M
|
$496.64 M
|
$440.13 M
|
$377.09 M
|
$384.09 M
|
$593.21 M
|
$340.87 M
|
| Interest Income |
$175.11 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$267.00 K
|
$173.00 K
|
| Interest Expense |
$220.54 M
|
$221.72 M
|
$235.53 M
|
$233.24 M
|
$234.60 M
|
$223.39 M
|
$208.72 M
|
$201.42 M
|
$220.24 M
|
$175.56 M
|
| Depreciation & Amortization |
$325.25 M
|
$304.65 M
|
$319.68 M
|
$332.41 M
|
$342.01 M
|
$329.92 M
|
$301.68 M
|
$281.28 M
|
$287.59 M
|
$267.06 M
|
| EBITDA |
$1.17 B |
$947.11 M |
$810.84 M |
$1.00 B |
$992.70 M |
$715.64 M |
$854.24 M |
$779.21 M |
$613.76 M |
$826.96 M |
| EBITDA Ratio |
0.98
|
0.9
|
0.85
|
1.14
|
0.93
|
0.8
|
0.92
|
0.88
|
0.68
|
0.92
|
| Operating Income Ratio |
0.63
|
0.63
|
0.51
|
0.45
|
0.53
|
0.51
|
0.59
|
0.56
|
0.35
|
0.62
|
| Total Other Income/Expenses Net |
-$125.23 M
|
-$231.00 M
|
-$233.92 M
|
$51.13 M
|
-$134.03 M
|
-$283.79 M
|
-$196.95 M
|
-$201.08 M
|
-$209.25 M
|
-$175.62 M
|
| Income Before Tax |
$624.22 M
|
$428.66 M
|
$255.05 M
|
$443.40 M
|
$432.14 M
|
$168.47 M
|
$354.79 M
|
$296.51 M
|
$105.92 M
|
$384.33 M
|
| Income Before Tax Ratio |
0.52
|
0.41
|
0.27
|
0.5
|
0.41
|
0.19
|
0.38
|
0.34
|
0.12
|
0.43
|
| Income Tax Expense |
$14.75 M
|
$10.86 M
|
$6.26 M
|
$4.56 M
|
$3.84 M
|
$4.93 M
|
$2.84 M
|
$3.01 M
|
$3.25 M
|
$1.41 M
|
| Net Income |
$590.11 M
|
$406.33 M
|
$242.18 M
|
$426.93 M
|
$416.74 M
|
$159.33 M
|
$341.12 M
|
$281.58 M
|
$100.42 M
|
$366.42 M
|
| Net Income Ratio |
0.49
|
0.39
|
0.25
|
0.49
|
0.39
|
0.18
|
0.37
|
0.32
|
0.11
|
0.41
|
| EPS |
2.02 |
1.57 |
1.01 |
1.81 |
1.76 |
0.7 |
1.6 |
1.41 |
0.51 |
1.91 |
| EPS Diluted |
1.94 |
1.55 |
1 |
1.8 |
1.75 |
0.68 |
1.54 |
1.34 |
0.51 |
1.9 |
| Weighted Average Shares Out |
$296.10 M
|
$258.12 M
|
$240.49 M
|
$236.26 M
|
$236.93 M
|
$227.74 M
|
$213.40 M
|
$200.28 M
|
$197.74 M
|
$191.78 M
|
| Weighted Average Shares Out Diluted |
$310.70 M
|
$270.45 M
|
$250.45 M
|
$244.29 M
|
$244.34 M
|
$235.10 M
|
$222.13 M
|
$209.71 M
|
$206.79 M
|
$201.64 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
